Hedgehog Pathway Inhibitors for Advanced Basal Cell Carcinoma: Optimizing Use in Clinical Practice
The 2026 ODAC Conference featured an expert panel discussion on evolving strategies for the use of hedgehog pathway inhibitors (HHIs), with a focus on practical clinical decision-making for dermatologists. Dr. Vishal Patel and Dr. C. William Hanke reviewed how HHIs have expanded treatment options for patients with locally advanced and metastatic basal cell carcinoma (BCC).
Background and Rational …
The 2026 ODAC Conference featured an expert panel discussion on evolving strategies for the use of hedgehog pathway inhibitors (HHIs), with a focus on practical clinical decision-making for dermatologists. Dr. Vishal Patel and Dr. C. William Hanke reviewed how HHIs have expanded treatment options for patients with locally advanced and metastatic basal cell carcinoma (BCC).
Background and Rational …